Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05CND
|
||||
Former ID |
DNC005403
|
||||
Drug Name |
6-(3-Nitro-phenyl)-3H-benzothiazol-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C13H8N2O3S
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC3=C(C=C2)NC(=O)S3
|
||||
InChI |
1S/C13H8N2O3S/c16-13-14-11-5-4-9(7-12(11)19-13)8-2-1-3-10(6-8)15(17)18/h1-7H,(H,14,16)
|
||||
InChIKey |
NGWRFPUBBONZGG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | Oocyte meiosis | ||||
Progesterone-mediated oocyte maturation | |||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
Reactome | Nuclear signaling by ERBB4 | ||||
Nuclear Receptor transcription pathway | |||||
WikiPathways | Ovarian Infertility Genes | ||||
Signaling by ERBB4 | |||||
Nuclear Receptors | |||||
References | |||||
REF 1 | J Med Chem. 2005 Aug 11;48(16):5092-5.Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potentand selective nonsteroidal progesterone receptor agonist tanaproget. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.